DJ Applied DNA Sciences Shares Up 13% on Licensing Deal >APDN
By Chris Wack
Applied DNA Sciences Inc. (APDN) shares rose 13% to $4.52 premarket after the company said its LineaRx Inc. subsidiary has signed a licensing agreement with LifeSensors Inc. to incorporate LifeSensors' high expression SUMO-fusion technologies into the company's linear DNA amplicons designed and produced for therapeutic applications.
Applied DNA said LineaRx will have a worldwide license to the applicable LifeSensors intellectual property to make, have made, use, and sell DNA constructs incorporating the SUMO-fusion technologies for therapeutic and diagnostic applications.
The companies said they will work together on initially developing and releasing two high expression amplicons: one for the generic Luciferase protein and one for its licensed anti-CD19 therapy.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
January 13, 2020 09:25 ET (14:25 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.